Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Demand & Sales Analysis by Product Type & Application The global protein expression market will witness a robust CAGR of 11.4%, valued at $2.45 billion in 2021, expected to appreciate and reach $6.47 billion by 2030, confirms Strategic Market Research. Based on Region, North America has considerable prospects for the market's major players. Protein expression is a biotechnological process for manufacturing a particular protein obtained naturally by manipulating gene expression in an individual to produce huge amounts of a recombinant gene. The ageing population, rising incidence of chronic illnesses and increased investment in protein-based research is likely to fuel market revenue growth throughout the forecasted period. Market Drivers - Increasing Occurrence of Target Illnesses, Rreat Effectiveness of Protein Therapies, Higher Adoption Rate The rising cases of illnesses such as cancer, cardiovascular disease, and genetic disorders are propelling the protein expression system market forward. Protein-based medications, such as insulin, for example, can cure a wide range of ailments with amazing efficacy. Furthermore, businesses are investing in protein expression systems research such as baculovirus expression systems (Insect cell expression systems), transient expression (Mammalian cells), and stable expression. Because of the great effectiveness of protein therapies, there is a low risk of adverse effects associated with protein therapeutics, which is driving the market growth significantly. Also, the transient protein expression market is driving the global market with the advancement of genetic engineering, which has opened up a slew of new routes and opportunities for large-scale protein expression and isolation. Market Restraints - Low R&D Spending, High Cost of Research, Lack of Professionals Low R & D spending, lack of standardization, lower rate of prevailing experts and the exorbitant cost of proteomics research are the crucial factors limiting the global industry growth. Opportunities - Increasing Incidence of Chronic Illnesses, the Introduction of Microfluidics, Technological Advancement The rise in the incidence of chronic diseases is likely to increase the growth of the market throughout the forecasted period. Furthermore, the increased demand for protein biologics is expected to boost the market size in the future. The introduction of microfluidics and the advancement of developing nations have provided a significant amount of development, which will create further chances for the protein expression systems market to grow in the future years. Market Analysis Of Different Segments Covered in the Report Based on System Type Prokaryotic Expression Systems Vagus Nerve Stimulation Escherichia coli Systems Other Systems Yeast Cell Expression Systems Kluyveromyces Lactis Systems Saccharomyces Systems Pichia Systems Other Systems Insect Cell Expression Systems Baculovirus Expression Systems Other Systems Cell-free Expression Systems Algal-based Expression Systems (protein expression system in E. coli) Based on Product and Service Reagents Expression Vectors Competent Cells Instruments Services Based on Application Therapeutic Applications Industrial Applications Research Applications Based on End-User Pharmaceutical and Biotechnology Companies Academic Research Institutes Contract Research Organizations (CROs) Other End Users Regional Coverage Analysis North America US Canada Rest of North America Europe Germany France UK Italy Spain Rest of Europe Asia - Pacific China Japan India Australia Rest of APAC Rest of the World Latin America Middle East & Africa Segments Analysis & Insights Based on System type, because of its wide acceptability, the cell-free protein expression has the largest market share, and this protein expression is carried out without the usage of live cells. This technology offers several benefits above other protein expression techniques and drives the industry technology, and it is commonly employed as a result of these advantages. The industry is growing due to cell-free protein approaches, such as enhanced speed, ability to produce hazardous proteins, and convenience of amino acid type-specific labelling. Based on Product and Service, the reagents segment is predicted to rise at a CAGR of 8.9% during the projection period. Acids and bases, acrylamides, buffers, cell lysis of carbohydrates, detergents, general reagents, protease inhibitors, and solvents are used in the protein expression process. These reagents have been used in research, industry, and pharmaceutical manufacturing. As a result, the market growth is projected to be aided by repeated purchases of reagents for various applications. Based on Application, the therapeutic segment is predicted to account for a major revenue share over the forecasted duration due to the adaption of protein in biologics production and growing preference for protein therapies to treat chronic diseases such as cancer, anaemia, haemophilia, multiple sclerosis, arthritis, and diabetes, among others. Based on End User, Pharmaceutical and biotechnology firms accounted for a substantial revenue share in the worldwide market in 2020, according to the end-use industry segment. The segment's revenue growth is fuelled by rising demand for biopharmaceuticals, fast advances in protein-based research, and increased investment and support for medication design (newly developed c protein marker) and development. Based on Region, North America has considerable prospects for the market's major players. Moreover, the fastest-growing industry in the Asia Pacific is predicted to grow at a strong 11.2 % CAGR throughout the projection period. Therefore, this area provides excellent protein market opportunities and is expected to develop at the fastest rate over the projected period. Protein Expression Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 2.45 Billion The revenue forecast in 2030 USD 6.47 Billion Growth rate CAGR of approximately 11.4% The base year for estimation 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product and Service, By System Type, By Application, By End-user, By Region By Product and Service Reagents, Expression Vectors, Competent Cells, Instruments, Services. By End-user Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs), Other End Users. By System Type Prokaryotic Expression Systems, Vagus Nerve Stimulation, Escherichia coli Systems, Yeast Cell Expression Systems, Kluyveromyces Lactis Systems, Saccharomyces Systems, Pichia Systems, Insect Cell Expression Systems, Baculovirus Expression Systems, Other Systems, Cell-free Expression Systems, Algal-based Expression Systems. By Application Therapeutic Applications, Industrial Applications, Research Applications By Region Asia Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Agilent Technologies Inc., Merck KGaA, Takara Bio Inc, New England Biolabs, BECTON, DICKINSON AND COMPANY, BIO-RAD LABORATORIES, INC., GenScript Biotech Corporation, LifeSensors Inc., Promega Corporation, QIAGEN NV., THERMO FISHER SCIENTIFIC, INC., Oxford Expression Technologies Ltd., Synthetic Genomics Inc. Global Protein Expression Market Competitive Landscape Analysis The competitive landscape analysis gives an overview of some prominent players operating in the market. Product innovation and continued R&D operations to create sophisticated technologies have assisted the growth. In the target market, there are many significant companies, and some of the market leaders are: Agilent Technologies Inc. Merck KGaA Takara Bio Inc New England Biolabs BECTON, DICKINSON AND COMPANY BIO-RAD LABORATORIES, INC. GenScript Biotech Corporation LifeSensors Inc. Promega Corporation QIAGEN NV. THERMO FISHER SCIENTIFIC, INC. Oxford Expression Technologies Ltd. Synthetic Genomics Inc. Recent Developments: On September 2021, Aviva Systems Biology, a global leader in antibodies, immunoassay kits, and recombinant proteins for life science research, announced the debut of their Protein on Demand service. Successful life science research requires high-quality recombinant proteins. While in-house protein manufacturing is possible, many laboratories and organizations lack the time or resources to do so. Aviva's launch of Protein on Demand semi-custom recombinant proteins intends to provide widespread access to the unique recombinant proteins required by academic researchers and small biotechs with ambitious research goals but limited resources. On June 2021, QIAprep& CRISPR Kit and CRISPR Q-Primer Solutions were released, allowing researchers to evaluate altered genetic material with unprecedented speed and efficiency to see how their interventions have impacted the function of the DNA sequence in the issue. The product's debut represents QIAGEN's first specialized solutions for the rapid field of CRISPR technology, which is used to edit genomes and adjust gene function. On January 2020, Merck announced a € 250 million investment in the Merck Biotech Development Center in Corsier-sur-Vevey, Switzerland, dedicated to biotech development and manufacturing for clinical trials. This project will help to sustainably secure capacity and high agility to deliver clinical trial material cost-effectively, contribute to accelerated development timelines for new biological entities, and identify the rising manufacturing complications of the next generations of biotech compounds, all driven by the growth of the Healthcare business sector R&D pipeline. Various Devices that the Market Leaders are Manufacturing Names Features Key Player TnT SP6 Single tube translation system that expresses protein in concentrations of 10-100 µg/ml in two hours Promega pEXP1-DEST Vector The ExpresswayTM Cell-free E. coli Production System allows for maximum expression of recombinant fusion proteins. THERMO FISHER SCIENTIFIC, INC. LB Agar Ampicillin-100 Used to make the RNAi library for Trypanosoma brucei Sigma Frequently Asked Question About This Report What is the protein expression market? Protein expression is a strategy for synthesizing, modifying, and regulating proteins in living organisms. Protein expression determines if one or more proteins are present in a cell or tissue. Pharmaceutical firms, biotechnology corporations, university research institutions, contract research organizations, and others employ protein expression for proteomics. And this market is called the protein expression market. What is the total market value of the global protein expression market? The global protein expression market share was USD 2.45 billion in 2021. However, it is predicted to reach USD 6.47 billion by 2030, with a CAGR of 11.4 % throughout the forecasted duration. What is the protein expression market growth? The global protein expression market is expected to grow at a compound annual growth rate (CAGR) of 11.4% from 2021 to 2030 to reach USD 6.47 billion by 2030. What is the best protein expression system? S. cerevisiae is one of the best protein expression systems. Which is commonly used for protein expression? E. coli is one of the most commonly used protein expression systems. What increases protein expression? Reducing the transcription rate, either by replacing a strong promoter with a weaker one or weakening a strong supporter by introducing a point mutation, can improve protein expression. How big is the global protein expression market? The global protein expression market size was $2.45 Bn in 2021 and is predicted to reach $6.47 Bn by 2030, with a CAGR of 11.4% during the forecasted period 2021 - 2030. 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Protein Expression Market 4.2.1 Global Market, 2021-2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by region, 2021-2030 (USD Million) 4.4 By System Type Business Analysis 4.4.1 Global Market, By System Type, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Global Market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Global Market, By Application, 2021-2030 (USD Million) 4.7 Product and Service Business Analysis 4.7.1 Global Market, By Product and Service, 2021-2030 (USD Million) 4.8 Value Chain Analysis 4.9 Market Variable Analysis 4.9.1 Market Drivers Analysis 4.9.2 Market Restraints Analysis 4.10 Business Environment Analysis Tool 4.10.1 Market PEST analysis 4.10.2 Market Porter’s analysis 4.11 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Product and Service Analysis 5.11.1. Trends in Product and Service (2014-2020) 5.11.2. Trends in Product and Service (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, System Type System Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By System Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Prokaryotic Expression Systems 7.3.1. Prokaryotic Expression Systems Market, 2021-2030 (USD Million) 7.3.1.1 Vagus Nerve Stimulation Market, 2021-2030 (USD Million) 7.3.1.2 Escherichia coli Systems Market, 2021-2030 (USD Million) 7.3.1.3 Other Systems Market, 2021-2030 (USD Million) 7.4. Yeast Cell Expression Systems Market, 2021-2030 (USD Million) 7.4.1. Yeast Cell Expression Systems Market, 2021-2030 (USD Million) 7.4.1.1 Kluyveromyces Lactis Systems Market, 2021-2030 (USD Million) 7.4.1.2 Saccharomyces Systems Market, 2021-2030 (USD Million) 7.4.1.3 Pichia Systems Market, 2021-2030 (USD Million) 7.4.1.4 Other Systems Market, 2021-2030 (USD Million) 7.5. Insect Cell Expression Systems Market, 2021-2030 (USD Million) 7.5.1. Insect Cell Expression Systems Market, 2021-2030 (USD Million) 7.5.1.1 Baculovirus Expression Systems Market, 2021-2030 (USD Million) 7.5.1.2 Other Systems Market, 2021-2030 (USD Million) 7.6. Cell-free Expression Systems Market, 2021-2030 (USD Million) 7.6.1. Cell-free Expression Systems Market, 2021-2030 (USD Million) 7.7. Algal-based Expression Systems Market, 2021-2030 (USD Million) 7.7.1. Algal-based Expression Systems Market, 2021-2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Pharmaceutical and Biotechnology Companies 8.3.1. Pharmaceutical and Biotechnology Companies Market, 2021-2030 (USD Million) 8.4. Academic Research Institutes 8.4.1. Academic Research Institutes Market, 2021-2030 (USD Million) 8.5. Contract Research Organizations (CROs) 8.5.1. Contract Research Organizations (CROs) Market, 2021-2030 (USD Million) 8.6. Other End Users 8.6.1. Other End Users Market, 2021-2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Therapeutic Applications 9.3.1. Therapeutic Applications Market, 2021-2030 (USD Million) 9.4. Industrial Applications 9.4.1. Industrial Applications Market, 2021-2030 (USD Million) 9.5. Research Applications 9.5.1. Research Applications Market, 2021-2030 (USD Million) 10. Global Market: By Product and Service Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Reagents 10.3.1. Reagents Market, 2021-2030 (USD Million) 10.4. Expression Vectors 10.4.1. Expression Vectors Market, 2021-2030 (USD Million) 10.5. Competent Cells 10.5.1. Competent Cells Market, 2021-2030 (USD Million) 10.6. Instruments 10.6.1. Instruments Market, 2021-2030 (USD Million) 10.7. Services 10.7.1. Services Market, 2021-2030 (USD Million) 11. Global Market: Regional Outlook 11.1 North America 11.1.1. North America Market, By System Type, 2021-2030 (USD Million) 11.1.2. North America Market, By End-User, 2021-2030 (USD Million) 11.1.3. North America Market, by Product and Service, 2021-2030 (USD Million) 11.1.4. North America Market, by Country, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. Market, By System Type, 2021-2030 (USD Million) 11.1.4.1.2. U.S. Market, By End-User, 2021-2030 (USD Million) 11.1.4.1.3. U.S. Market, by Product and Service, 2021-2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada Market, By System Type, 2021-2030 (USD Million) 11.1.4.2.2. Canada Market, By End-User, 2021-2030 (USD Million) 11.1.4.2.3. Canada Market, by Product and Service, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe Market, By System Type, 2021-2030 (USD Million) 11.2.2. Europe Market, By End-User, 2021-2030 (USD Million) 11.2.3. Europe Market, by Product and Service, 2021-2030 (USD Million) 11.2.4. Europe Market, by country, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. Market, By System Type, 2021-2030 (USD Million) 11.2.4.1.2. U.K. Market, By End-User, 2021-2030 (USD Million) 11.2.4.1.3. U.K. Market, by Product and Service, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany Market, By System Type, 2021-2030 (USD Million) 11.2.4.2.2. Germany Market, By End-User, 2021-2030 (USD Million) 11.2.4.2.3. Germany Market, by Product and Service, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France Market, By System Type, 2021-2030 (USD Million) 11.2.4.3.2. France Market, By End-User, 2021-2030 (USD Million) 11.2.4.3.3. France Market, by Product and Service, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe Market, By System Type, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe Market, By End-User, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe Market, by Product and Service, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific Market, By System Type, 2021-2030 (USD Million) 11.3.2. Asia Pacific Market, By End-User, 2021-2030 (USD Million) 11.3.3. Asia Pacific Market, by Product and Service, 2021-2030 (USD Million) 11.3.4. Asia Pacific Market, by country, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China Market, By System Type, 2021-2030 (USD Million) 11.3.4.1.2. China Market, By End-User, 2021-2030 (USD Million) 11.3.4.1.3. China Market, by Product and Service, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India Market, By System Type, 2021-2030 (USD Million) 11.3.4.2.2. India Market, By End-User, 2021-2030 (USD Million) 11.3.4.2.3. India Market, by Product and Service, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan Market, By System Type, 2021-2030 (USD Million) 11.3.4.3.2. Japan Market, By End-User, 2021-2030 (USD Million) 11.3.4.3.3. Japan Market, by Product and Service, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea Market, By System Type, 2021-2030 (USD Million) 11.3.4.4.2. South Korea Market, By End-User, 2021-2030 (USD Million) 11.3.4.4.3. South Korea Market, by Product and Service, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC Market, By System Type, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC Market, by Product and Service, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America Market, By System Type, 2021-2030 (USD Million) 11.4.2. Latin America Market, By End-User, 2021-2030 (USD Million) 11.4.3. Latin America Market, by Product and Service, 2021-2030 (USD Million) 11.4.4. Latin America Market, by country, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil Market, By System Type, 2021-2030 (USD Million) 11.4.4.1.2. Brazil Market, By End-User, 2021-2030 (USD Million) 11.4.4.1.3. Brazil Market, by Product and Service, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico Market, By System Type, 2021-2030 (USD Million) 11.4.4.2.2. Mexico Market, By End-User, 2021-2030 (USD Million) 11.4.4.2.3. Mexico Market, by Product and Service, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America Market, By System Type, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America Market, By End-User, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America Market, by Product and Service, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA Market, By System Type, 2021-2030 (USD Million) 11.5.2. MEA Market, By End-User, 2021-2030 (USD Million) 11.5.3. MEA Market, by Product and Service, 2021-2030 (USD Million) 11.5.4. MEA Market, by Region, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 Agilent Technologies Inc 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. System Type Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Merck KGaA 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. System Type Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Takara Bio Inc 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. System Type Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. New England Biolabs 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. System Type Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. BECTON, DICKINSON AND COMPANY 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. System Type Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. BIO-RAD LABORATORIES, INC. 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. System Type Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. GenScript Biotech Corporation 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. System Type Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. LifeSensors Inc. 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. System Type Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Promega Corporation 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. System Type Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. QIAGEN NV 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. System Type Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. THERMO FISHER SCIENTIFIC, INC. 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. System Type Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. Oxford Expression Technologies Ltd. 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. System Type Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. Synthetic Genomics Inc. 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. System Type Portfolio Analysis 12.13.4. Business Strategy & Recent Development List of Tables (63 Tables) TABLE 1. Market, By System Type, 2021-2030 (USD Million) TABLE 2. Market FOR Prokaryotic Expression Systems, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Vagus Nerve Stimulation, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Escherichia coli Systems, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Other Systems, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Yeast Cell Expression Systems, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Kluyveromyces Lactis Systems, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Saccharomyces Systems, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Pichia Systems, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Other Systems, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Insect Cell Expression Systems, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Baculovirus Expression Systems, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Other Systems, BY REGION, 2021-2030 (USD Million) TABLE 14. Market FOR Cell-free Expression Systems, BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Algal-based Expression Systems (protein expression system in E. coli), BY REGION, 2021-2030 (USD Million) TABLE 16. Market, By End-User, 2021-2030 (USD Million) TABLE 17. Market FOR Pharmaceutical and Biotechnology Companies, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Academic Research Institutes, BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Contract Research Organizations (CROs), BY REGION, 2021-2030 (USD Million) TABLE 20. Market Other End Users Organizations (CROs), BY REGION, 2021-2030 (USD Million) TABLE 21. Market, BY PRODUCT AND SERVICE, 2021-2030 (USD Million) TABLE 22. Market FOR Reagents, BY REGION, 2021-2030 (USD Million) TABLE 23. Market FOR Expression Vectors, BY REGION, 2021-2030 (USD Million) TABLE 24. Market FOR Competent Cells, BY REGION, 2021-2030 (USD Million) TABLE 25. Market FOR Instruments, BY REGION, 2021-2030 (USD Million) TABLE 26. Market FOR Services, BY REGION, 2021-2030 (USD Million) TABLE 27. Market, BY Application, 2021-2030 (USD Million) TABLE 28. Market FOR Therapeutic Applications, BY REGION, 2021-2030 (USD Million) TABLE 29. Market FOR Industrial Applications, BY REGION, 2021-2030 (USD Million) TABLE 30. Market FOR Research Applications, BY REGION, 2021-2030 (USD Million) TABLE 31. Market, BY REGION, 2021-2030 (USD Million) TABLE 32. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. NORTH AMERICA Market, By System Type, 2021-2030 (USD Million) TABLE 34. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 35. NORTH AMERICA Market, BY PRODUCT AND SERVICE, 2021-2030 (USD Million) TABLE 36. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 37. EUROPE Market, By System Type, 2021-2030 (USD Million) TABLE 38. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 39. EUROPE Market, BY PRODUCT AND SERVICE, 2021-2030 (USD Million) TABLE 40. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 41. ASIA-PACIFIC Market, By System Type, 2021-2030 (USD Million) TABLE 42. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 43. ASIA-PACIFIC Market, BY PRODUCT AND SERVICE, 2021-2030 (USD Million) TABLE 44. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 45. LAMEA Market, By System Type, 2021-2030 (USD Million) TABLE 46. LAMEA Market, By Application, 2021-2030 (USD Million) TABLE 47. LAMEA Market, BY PRODUCT AND SERVICE, 2021-2030 (USD Million) TABLE 48. Agilent Technologies Inc: COMPANY SNAPSHOT TABLE 49. Agilent Technologies Inc: OPERATING SEGMENTS TABLE 50. Merck KGaA: COMPANY SNAPSHOT TABLE 51. Merck KGaA: OPERATING SEGMENTS TABLE 52. Takara Bio Inc: COMPANY SNAPSHOT TABLE 53. Takara Bio Inc: OPERATING SEGMENTS TABLE 54. New England Biolabs: COMPANY SNAPSHOT TABLE 55. New England Biolabs: OPERATING SEGMENTS TABLE 56. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT TABLE 57. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS TABLE 58. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT TABLE 59. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS TABLE 60. GenScript Biotech Corporation: COMPANY SNAPSHOT TABLE 61. GenScript Biotech Corporation: OPERATING SEGMENTS TABLE 62. LifeSensors Inc.: COMPANY SNAPSHOT TABLE 63. LifeSensors Inc.: OPERATING SEGMENTS TABLE 64. Promega Corporation: COMPANY SNAPSHOT TABLE 65. Promega Corporation: OPERATING SEGMENTS TABLE 66. QIAGEN NV: COMPANY SNAPSHOT TABLE 67. QIAGEN NV: OPERATING SEGMENTS TABLE 68. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT TABLE 69. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS TABLE 70. Oxford Expression Technologies Ltd.: COMPANY SNAPSHOT TABLE 71. Oxford Expression Technologies Ltd.: OPERATING SEGMENTS TABLE 72. Synthetic Genomics Inc.: COMPANY SNAPSHOT TABLE 73. Synthetic Genomics Inc.: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: System Type-Based Estimation Figure 6 Top 13 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Protein Expression, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Protein Expression, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Product and Service, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By System Type, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 cell-free protein expression to Witness Higher CAGR in Market for System Type Segment during Forecast Period. Figure 17 Reagents to Witness Higher CAGR in Market for Product and Service Segment during Forecast Period. Figure 18 Pharmaceutical and Biotechnology Companies to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 19 Therapeutic Applications to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview